Comparison of individual and combination DNA vaccines for B. anthracis, Ebola virus, Marburg virus and Venezuelan equine encephalitis virus
- PMID: 12922144
- DOI: 10.1016/s0264-410x(03)00362-1
Comparison of individual and combination DNA vaccines for B. anthracis, Ebola virus, Marburg virus and Venezuelan equine encephalitis virus
Abstract
Multiagent DNA vaccines for highly pathogenic organisms offer an attractive approach for preventing naturally occurring or deliberately introduced diseases. Few animal studies have compared the feasibility of combining unrelated gene vaccines. Here, we demonstrate that DNA vaccines to four dissimilar pathogens that are known biowarfare agents, Bacillus anthracis, Ebola (EBOV), Marburg (MARV), and Venezuelan equine encephalitis virus (VEEV), can elicit protective immunity in relevant animal models. In addition, a combination of all four vaccines is shown to be equally as effective as the individual vaccines for eliciting immune responses in a single animal species. These results demonstrate for the first time the potential of combined DNA vaccines for these agents and point to a possible method of rapid development of multiagent vaccines for disparate pathogens such as those that might be encountered in a biological attack.
Similar articles
-
DNA vaccines for biodefense.Expert Rev Vaccines. 2009 Dec;8(12):1739-54. doi: 10.1586/erv.09.132. Expert Rev Vaccines. 2009. PMID: 19943766 Review.
-
Multiagent vaccines vectored by Venezuelan equine encephalitis virus replicon elicits immune responses to Marburg virus and protection against anthrax and botulinum neurotoxin in mice.Vaccine. 2006 Nov 17;24(47-48):6886-92. doi: 10.1016/j.vaccine.2006.06.004. Epub 2006 Jun 21. Vaccine. 2006. PMID: 16828936
-
Vaccine research efforts for filoviruses.Int J Parasitol. 2003 May;33(5-6):583-95. doi: 10.1016/s0020-7519(03)00064-x. Int J Parasitol. 2003. PMID: 12782057 Review.
-
A single shot against Ebola and Marburg virus.Nat Med. 2005 Jul;11(7):720-1. doi: 10.1038/nm0705-720. Nat Med. 2005. PMID: 16015361 No abstract available.
-
Ebola and Marburg virus vaccines.Virus Genes. 2017 Aug;53(4):501-515. doi: 10.1007/s11262-017-1455-x. Epub 2017 Apr 26. Virus Genes. 2017. PMID: 28447193 Free PMC article. Review.
Cited by
-
A DNA vaccine producing LcrV antigen in oligomers is effective in protecting mice from lethal mucosal challenge of plague.Vaccine. 2004 Sep 3;22(25-26):3348-57. doi: 10.1016/j.vaccine.2004.02.036. Vaccine. 2004. PMID: 15308359 Free PMC article.
-
Vaccines against Ebola virus and Marburg virus: recent advances and promising candidates.Hum Vaccin Immunother. 2019;15(10):2359-2377. doi: 10.1080/21645515.2019.1651140. Epub 2019 Oct 7. Hum Vaccin Immunother. 2019. PMID: 31589088 Free PMC article. Review.
-
Ebola: Lessons on Vaccine Development.Annu Rev Microbiol. 2018 Sep 8;72:423-446. doi: 10.1146/annurev-micro-090817-062414. Annu Rev Microbiol. 2018. PMID: 30200851 Free PMC article. Review.
-
Marburg virus disease: A summary for clinicians.Int J Infect Dis. 2020 Oct;99:233-242. doi: 10.1016/j.ijid.2020.07.042. Epub 2020 Aug 3. Int J Infect Dis. 2020. PMID: 32758690 Free PMC article. Review.
-
An update on nonhuman primate usage for drug and vaccine evaluation against filoviruses.Expert Opin Drug Discov. 2024 Oct;19(10):1185-1211. doi: 10.1080/17460441.2024.2386100. Epub 2024 Aug 18. Expert Opin Drug Discov. 2024. PMID: 39090822 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical